Prostate-Specific Antigen Response to Withdrawal of Megestrol Acetate in a Patient With Hormone-Refractory Prostate Cancer
- 1 October 1997
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 72 (10) , 932-934
- https://doi.org/10.4065/72.10.932
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995
- Prostate-specific antigen decline after casodex withdrawal: Evidence for an antiandrogen withdrawal syndromeUrology, 1994
- Response to Flutamide Withdrawal in Advanced Prostate Cancer in Progression Under Combination TherapyJournal of Urology, 1993
- Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.Journal of Clinical Oncology, 1993
- Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal SyndromeJournal of Urology, 1993
- Carcinoma of the ProstateNew England Journal of Medicine, 1991
- Megestrol Acetate in Relapsed Carcinoma of ProstateBritish Journal of Urology, 1990
- Treatment of advanced cancer of prostate with megestrol acetateUrology, 1978
- Effect of Megestrol Acetate (Megace®) on Steroid Metabolism and Steroid-Protein Binding in the Human ProstateJournal of Clinical Endocrinology & Metabolism, 1976